Absorbed dose behind eye shields during kilovoltage photon radiotherapy.
The absorbed dose at the position of the lens of the eye under lead or tungsten eye shields during kilovoltage photon radiotherapy is critically dependent not so much on the thickness of the eye shield itself as on the size of the treatment field and the diameter of the shield used. Whilst dose from primary photons is easily attenuated to relatively insignificant levels by a few millimetres of lead or tungsten, scattered photons from outside the shielded area can provide over 25% of the prescribed dose. Since backscatter factors do not increase monotonically with photon energy, it is not safe to assume that the highest photon energy used will provide the highest dose. A simple method to estimate the dose under an eye shield based on tabulated backscatter factors is shown. Measurements under commercially available eye shields were made to verify the expression and to determine the attenuation of primary photons. Predicted and measured absorbed dose under the eye shields were found to agree to within 1% of the prescribed dose. The relative dose due to primary photons beneath the eye shields was found to be less than 0.1% and 0.5 (+/-0.1)% for the 150 kV and 260 kV beams, respectively. This is considerably less than the dose from backscattered radiation.
Baker
C R
CR
Medical Physics Department, Box 152, Addenbrooke's NHS Trust, Hills Road, Cambridge CB2 2QQ, UK.
Luhana
F
F
Thomas
S J
SJ
D005135:Eye Protective Devices; D006801:Humans; D017785:Photons; D011829:Radiation Dosage; D011878:Radiotherapy / Q000009:adverse effects*; D012542:Scattering, Radiation; D014414:Tungsten
D014414:Tungsten